CTLA4 and cancer: Despite the lack of correlation between CTLA-4 ligand expression and a specific cancer cell type and the fact that Ctla-4-knockout mice models predicted lethal autoimmune phenotypes, it was shown that CTLA-4 inhibition produced antitumoral responses in preclinical cancer models (163).